Diabetes

A nationwide telemedicine diabetic screening program could help prevent diabetic retinopathy, the top cause of new-onset blindness in the United States.

Researchers and patients alike are increasingly interested in therapies that do more to limit the day-to-day, and hour-to-hour fluctuations in blood glucose that consume the time and energy of those living with diabetes.

The authors are among those concerned that patients with diabetes may be given more medication than they can tolerate or afford to achieve small improvements in A1C, without any other health benefits.

Payer coverage has been cited as the most frequent barrier to patient access to obesity therapy. While most new obesity therapies have lower wholesale costs than SGLT2 inhibitors, lack of coverage puts them out of reach for most Americans, according to a new study.

Not only are patients with prediabetes benefiting from Omada Health’s Prevent program, Omada benefits as well by learning from the enrolled patients about how to better serve the Medicaid population, Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.

Researchers found a dose-response relationship for several cancers involved in eating, meaning the higher the weight, the greater risk of cancer.

Researchers found that changing cooking methods could allow people at risk of developing diabetes to reverse damage done by things like grilling and frying their food.

The study in JAMA represents the largest effort to date to integrate mental health and primary care services across a health system and measure both clinical outcomes and savings.

For years, researchers have looked for a solution that would mean fewer injections for those with type 1 diabetes.

Governor Phil Bryant's opposition to expansion contrasts with his public support for other healthcare initiatives, such as a new diabetes research center and telehealth research.

The recommendation comes after a review of evidence of how sugar consumption affects children's health. FDA is scheduled to add information on added sugar to food labels in 2018.

Medication adherence is a complex issue, and Lonny Reisman, MD, CEO of HealthReveal, emphasized the importance of better understanding what methods or strategies will help motivate patients to do what is in their best interest.

A $245 million priority review voucher is essentially wasted, not over the therapy, but the delivery device.

Diabetes advocate Kelly Close of diaTribe and Close Concerns wrote in a blog post that those with diabetes can make a video to share with the FDA.

The authors found that comorbidity burden and the direction of behavioral change influence the relationship between adherence and medical spend. This could affect the cost-benefit considerations of medication adherence programs.

This week, the top stories in managed care included Aetna's announcement that it was pulling back its participation on the Affordable Care Act exchanges, the annual meeting of the American Association of Diabetes Educators outlined how existing sites can help roll out the Diabetes Prevention Program nationwide, and hospital leaders gave their opinions on CMS' hospital readmission program.

Highlights from the recent gathering of the American Association of Diabetes Educators, which met August 12-15, 2016, in San Diego, California.

Adrenal gland tumors that are defined as being nonfunctional may not really be so, and the hormones that these tumors secrete could increase an individual’s risk of cardiometabolic irregularities, according to a new study.

A nonprofit that provides free sports physicals was able to gather data that revealed important population health findings.

The findings suggest that the improved glycemic control that often comes with bariatric surgery may have a role in affecting the brain's response to food.

The researcher, Kyle Fluegge, PhD, found that just comparing fluoride levels by parts per million showed little, but comparisons based on how much water people drank were revealing.

Researchers found that drug prices would need to be less than one-third of their current retail value to be cost-effective.

Work at the University of Montreal shows how a urea impacts a protein, disrupting insulin secretion and elevating blood glucose.

While there has been some recent progress, bias pervades healthcare when it comes to obesity treatment. This gives patients less access to care than they receive for other chronic conditions, even though obesity causes some of those conditions.